Clinical Trials Browser

Phase 1/2 × Craniopharyngioma × 1 year × Clear all

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT06970145 2025-11-18

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Phase 1/2 Recruiting

57 enrolled

CNS

Craniopharyngioma

Clinical Trials

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma